NCT04711187View on ClinicalTrials.gov

Study of AT-527 in Healthy Subjects (R07496998)

PHASE1CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

November 2, 2020

Primary Completion Date

September 15, 2021

Study Completion Date

September 15, 2021

Conditions
Healthy Volunteer Study
Interventions
DRUG

AT-527 Formulation 1

AT-527 Formulation 1 (R07496998)

OTHER

Placebo Comparator

Placebo Comparator

DRUG

AT-527 Formulation 2

AT-527 Formulation 2 (R07496998)

Trial Locations (1)

Unknown

Atea Study Site, Montreal

Sponsors
All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

Atea Pharmaceuticals, Inc.

INDUSTRY

NCT04711187 - Study of AT-527 in Healthy Subjects (R07496998) | Biotech Hunter | Biotech Hunter